Brief: Bio-Gene Technology Grants STK Bio-Ag Technologies Non-Exclusive Licence To Develop Qcidetm
19/01/2023 01:17
Jan 19 (Reuters) - Bio-Gene Technology Ltd BGT.AX :
* BIO-GENE GRANTS STK A WORLD-WIDE NON-EXCLUSIVE LICENCE TO
DEVELOP QCIDETM
* TO HAVE FULL ACCESS TO ACTIVE INGREDIENT REGISTRATIONS TO
SUPPORT OTHER COMMERCIAL OPPORTUNITIES IN CROP, NON-CROP
APPLICATIONS
* STK BIO-AG TECHNOLOGIES FUNDS ALL COSTS ASSOCIATED WITH
SECURING
THE ACTIVE INGREDIENT REGISTRATION FOR QCIDE
Further company coverage: BGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio-Gene Technology
See all newsBrief: Bio-Gene Technology Receives Total Placement Commitments Of A$2.78 Million
Australia's Bio-Gene Technology slips to 4-1/2-month low on discounted placement
Brief: Bio-Gene Technology Ltd Raises A$3.21 MLN Via Placement, Partially Underwritten Share Purchase Plan
Brief: Bio-Gene Technology Seeks Trading Halt
Australia's Bio‑Gene surges on Asia expansion optimism for mosquito control products